Profil
Sandy D.
Der is the founder of ImmVue Therapeutics.
Dr. Der is a Partner at Novatio Ventures since 2015.
Dr. Der was COO at Ardra, Inc. from 2019 to 2022.
Dr. Der completed undergraduate and doctorate degrees at the University of Toronto in 1997.
Postes actifs de Sandy Der
| Sociétés | Poste | Début |
|---|---|---|
Novatio Ventures
Novatio Ventures Investment ManagersFinance Novatio Ventures invests in companies located Canada, U.S., China, South Korea, and other markets. The firm focuses on companies in the filed of high-impact life science. It participates in seed and early stage capital requirements. | Private Equity Investor | 01/10/2015 |
Anciens postes connus de Sandy Der
| Sociétés | Poste | Fin |
|---|---|---|
Ardra, Inc.
Ardra, Inc. Chemicals: Major DiversifiedProcess Industries Manufactures petroleum-free and specialty chemicals | Directeur des opérations | 01/12/2022 |
Formation de Sandy Der
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardra, Inc.
Ardra, Inc. Chemicals: Major DiversifiedProcess Industries Manufactures petroleum-free and specialty chemicals | Process Industries |
Novatio Ventures
Novatio Ventures Investment ManagersFinance Novatio Ventures invests in companies located Canada, U.S., China, South Korea, and other markets. The firm focuses on companies in the filed of high-impact life science. It participates in seed and early stage capital requirements. | Finance |
















